Annual EBITDA
-$74.30 M
+$66.83 M+47.35%
31 December 2023
Summary:
Celularity annual earnings before interest, taxes, depreciation & amortization is currently -$74.30 million, with the most recent change of +$66.83 million (+47.35%) on 31 December 2023. During the last 3 years, it has fallen by -$8.85 million (-13.52%). CELUW annual EBITDA is now -13.52% below its all-time high of -$65.45 million, reached on 31 December 2020.CELUW EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
-$13.17 M
-$3.22 M-32.39%
30 September 2024
Summary:
Celularity quarterly earnings before interest, taxes, depreciation & amortization is currently -$13.17 million, with the most recent change of -$3.22 million (-32.39%) on 30 September 2024. Over the past year, it has dropped by -$374.00 thousand (-2.92%). CELUW quarterly EBITDA is now -125.65% below its all-time high of $51.33 million, reached on 30 September 2021.CELUW Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
-$40.06 M
-$374.00 K-0.94%
30 September 2024
Summary:
Celularity TTM earnings before interest, taxes, depreciation & amortization is currently -$40.06 million, with the most recent change of -$374.00 thousand (-0.94%) on 30 September 2024. Over the past year, it has increased by +$79.98 million (+66.63%). CELUW TTM EBITDA is now -427.55% below its all-time high of $12.23 million, reached on 30 June 2020.CELUW TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CELUW EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +47.4% | -2.9% | +66.6% |
| 3 y3 years | -13.5% | -125.7% | -49.2% |
| 5 y5 years | - | - | - |
CELUW EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -13.5% | +47.9% | -125.7% | +74.9% | -494.5% | +74.8% |
| 5 y | 5 years | -13.5% | +47.9% | -125.7% | +83.3% | -427.6% | +74.8% |
| alltime | all time | -13.5% | +47.9% | -125.7% | +83.3% | -427.6% | +74.8% |
Celularity EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$13.17 M(+32.4%) | -$40.06 M(+0.9%) |
| June 2024 | - | -$9.95 M(+67.8%) | -$39.68 M(-23.3%) |
| Mar 2024 | - | -$5.93 M(-46.2%) | -$51.73 M(-47.3%) |
| Dec 2023 | -$74.30 M(-47.4%) | -$11.02 M(-13.8%) | -$98.22 M(-18.2%) |
| Sept 2023 | - | -$12.79 M(-41.8%) | -$120.03 M(-15.8%) |
| June 2023 | - | -$22.00 M(-58.0%) | -$142.64 M(-10.1%) |
| Mar 2023 | - | -$52.41 M(+59.6%) | -$158.74 M(+12.5%) |
| Dec 2022 | -$141.13 M | -$32.84 M(-7.2%) | -$141.13 M(+29.5%) |
| Sept 2022 | - | -$35.40 M(-7.1%) | -$108.95 M(+390.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2022 | - | -$38.10 M(+9.5%) | -$22.22 M(-318.8%) |
| Mar 2022 | - | -$34.80 M(+5213.3%) | $10.15 M(-130.0%) |
| Dec 2021 | -$142.74 M(+118.1%) | -$655.00 K(-101.3%) | -$33.90 M(+26.3%) |
| Sept 2021 | - | $51.33 M(-996.9%) | -$26.84 M(-78.2%) |
| June 2021 | - | -$5.72 M(-92.7%) | -$123.00 M(+17.1%) |
| Mar 2021 | - | -$78.85 M(-1332.4%) | -$105.04 M(+301.0%) |
| Dec 2020 | -$65.45 M | $6.40 M(-114.3%) | -$26.19 M(-19.6%) |
| Sept 2020 | - | -$44.82 M(-466.5%) | -$32.59 M(-366.5%) |
| June 2020 | - | $12.23 M | $12.23 M |
FAQ
- What is Celularity annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for Celularity?
- What is Celularity annual EBITDA year-on-year change?
- What is Celularity quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for Celularity?
- What is Celularity quarterly EBITDA year-on-year change?
- What is Celularity TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for Celularity?
- What is Celularity TTM EBITDA year-on-year change?
What is Celularity annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of CELUW is -$74.30 M
What is the all time high annual EBITDA for Celularity?
Celularity all-time high annual earnings before interest, taxes, depreciation & amortization is -$65.45 M
What is Celularity annual EBITDA year-on-year change?
Over the past year, CELUW annual earnings before interest, taxes, depreciation & amortization has changed by +$66.83 M (+47.35%)
What is Celularity quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of CELUW is -$13.17 M
What is the all time high quarterly EBITDA for Celularity?
Celularity all-time high quarterly earnings before interest, taxes, depreciation & amortization is $51.33 M
What is Celularity quarterly EBITDA year-on-year change?
Over the past year, CELUW quarterly earnings before interest, taxes, depreciation & amortization has changed by -$374.00 K (-2.92%)
What is Celularity TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of CELUW is -$40.06 M
What is the all time high TTM EBITDA for Celularity?
Celularity all-time high TTM earnings before interest, taxes, depreciation & amortization is $12.23 M
What is Celularity TTM EBITDA year-on-year change?
Over the past year, CELUW TTM earnings before interest, taxes, depreciation & amortization has changed by +$79.98 M (+66.63%)